Altex

SJR Rank #4,173H-index: 74SJR: 1.101Best quartile: Q1Open AccessAPC: US$2,157Listed in DOAJ
Journal website: aims, scope and author guidelines
Publisher

ALTEX Edition

Country

Germany

Type

journal

SJR by Edition

2022202500.30.60.91.2

Subject Categories

  • Medical Laboratory TechnologyQ1
  • Medicine (miscellaneous)Q1
  • PharmacologyQ1

Areas: Health Professions · Medicine · Pharmacology, Toxicology and Pharmaceutics

Most published research topics

Animal testing and alternativesComputational Drug Discovery MethodsEffects and risks of endocrine disrupting chemicals3D Printing in Biomedical ResearchContact Dermatitis and AllergiesAgricultural safety and regulationsPluripotent Stem Cells ResearchCarcinogens and Genotoxicity AssessmentEnvironmental Toxicology and EcotoxicologyImmunotoxicology and immune responses

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs04590135180

Documents per Year

20222025020406080

Detailed Information

ISSN

1868-596X, 1868-8551

SJR Best Quartile

Q1

Region

Western Europe

Citations per Document (2 years)

4.18

References per Document

49.94

Coverage

2000-2026

Scope

ALTEX – Alternatives to Animal Experimentation publishes open access academic articles on the development and implementation of alternatives to the use of animals for scientific purposes and informs on international developments in this field. The use of animals for scientific purposes includes all experimental procedures involving the use of animals in testing, research, and education or to obtain tissues, organs, and other animal-derived products which may cause pain, suffering, distress or lasting harm to animals. ALTEX is committed to ensuring that all research published gives full consideration to animal welfare and ethical issues. ALTEX publishes research articles, concept articles, opinion articles, reviews, consensus reports, short communications, letters, comments, corners and meeting reports. Current news and events are posted online.

Metrics from SCImago Journal Rank 2025. View on SCImago